iNtRON Biotechnology

인트론바이오테크놀로지KRX: 048530· Fiscal year 2025· intron.co.kr ↗

Average salary
$48.9K
₩65.1M
▲ 23.8% vs 2024
Employees
77
▲ 10.0% vs 2024
Average tenure
7.5 yrs

Estimated take-home of this pay:$3.4K / monthCalculate →

Workplace

Women's pay (men = 100)49
Women among staff41.6%
Contract staff1.3%

Recent official filings

Quick read

  • Average pay is 7% above the median of the companies we track.
  • Average pay rose 23.8% from 2024.
  • Headcount grew by 7 (10.0%) from 2024.
  • Ranks #72 of 238 Healthcare & Pharma companies in this country by pay.
  • Revenue fell 10.6% year over year.
  • Revenue has shrunk two years in a row.
  • Operating loss of $5.9M in 2025.

Last 3 years

Revenue
$7.2M2023$4.8M2024$4.3M2025
Operating income
-$2.5M2023-$3.9M2024-$5.9M2025

See the share price on Naver Finance ↗

Investor metrics

2025
Revenue per employee
$55.8K
Net profit per employee
-$87.1K
Operating margin
-137.7%
Net margin
-156.1%
ROE
-12.8%
Debt-to-equity
6.4%
Equity ratio
94.0%

Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.

Similar companies

USD at ₩1,332.22 per $1 (2026-11-19, ExchangeRate-API)

Source: DART (Financial Supervisory Service, Korea)

Not investment advice. Figures come from public filings and may contain errors.